Dear colleagues!

Announcement of the submission for discussion of the draft Clinical Protocol on the topic: “Systemic radionuclide therapy of bone metastases with the radiopharmaceutical drug samarium-153” is a significant step towards standardization and improving the effectiveness of treatment of patients suffering from this pathology.

This protocol was developed in order to define modern standards for the use of the radiopharmaceutical drug Samaria-153 in the treatment of patients with bone metastases. Our goal is to provide optimal clinical outcomes for patients suffering from this disease.

We invite all interested specialists — doctors, scientists, researchers, as well as representatives of healthcare organizations — to familiarize themselves with the draft Protocol and make their suggestions and comments.

The discussion will be held in an open format with the possibility of sending comments via email.

Your contribution and recommendations are of great importance for the formation of the final document and ensuring high-quality medical care for patients with this pathology.

Contact information for sending comments and suggestions: mail@semeyonco.kz

Thank you for your participation and active assistance in the development of medical standards!